PMID- 24840404 OWN - NLM STAT- MEDLINE DCOM- 20150114 LR - 20151119 IS - 1791-2431 (Electronic) IS - 1021-335X (Linking) VI - 32 IP - 1 DP - 2014 Jul TI - Gastric cancer cell adhesion to laminin enhances acquired chemotherapeutic drug resistance mediated by MGr1-Ag/37LRP. PG - 105-14 LID - 10.3892/or.2014.3184 [doi] AB - Adhesion of cancer cells to the extracellular matrix (ECM) causes a novel acquired chemotherapeutic drug‑resistant phenotype, referred to as cell adhesion-mediated drug resistance (CAM-DR). Our previous studies suggested that the adhesion molecule MGr1-Ag/37LRP may promote multidrug resistance in gastric cancer cells. Therefore, we investigated MGr1-Ag/37LRP binding-induced adhesion, and its role in CAM-DR. Initial studies revealed that, after adhesion to the ECM, the multidrug-resistant gastric cancer cell lines SGC7901/VCR and SGC7901/ADR showed significantly higher mean adhesive cell numbers than non‑resistant SGC7901 cells. We then investigated expression of MGr1-Ag/37LRP in gastric cancer cells adhering to laminin. Western blotting, RT-PCR and dual-luciferase reporter assays showed that laminin induced MGr1-Ag/37LRP expression and activity. In vitro and in vivo assays revealed that small interfering RNA against MGr1-Ag/37LRP significantly reduced CAM-DR in SGC7901/VCR cells. In vivo and in vitro analyses revealed that binding of MGr1-Ag/37LRP decreased intracellular drug accumulation by increasing P-glycoprotein and multidrug-associated protein expression, and inhibited drug-induced apoptosis by regulating Bcl-2 and Bax expression. These results indicate that MGr1-Ag/37LRP contributes to laminin-mediated CAM-DR in gastric cancer cells, and is a potentially effective target for reversing this phenomenon in gastric cancer. FAU - Sun, Li AU - Sun L AD - State Key Laboratory of Cancer Biology, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an 710032, P.R. China. FAU - Liu, Lili AU - Liu L AD - Department of Oncology, Tangdu Hospital, Fourth Military Medical University, Xi'an 710038, P.R. China. FAU - Liu, Xiangqiang AU - Liu X AD - State Key Laboratory of Cancer Biology, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an 710032, P.R. China. FAU - Wang, Yafang AU - Wang Y AD - Department of Oncology, Tangdu Hospital, Fourth Military Medical University, Xi'an 710038, P.R. China. FAU - Li, Mengbin AU - Li M AD - State Key Laboratory of Cancer Biology, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an 710032, P.R. China. FAU - Yao, Liping AU - Yao L AD - State Key Laboratory of Cancer Biology, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an 710032, P.R. China. FAU - Yang, Jianjun AU - Yang J AD - State Key Laboratory of Cancer Biology, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an 710032, P.R. China. FAU - Ji, Genlin AU - Ji G AD - Department of Anesthesiology, Xijing Hospital, Fourth Military Medical University, Xi'an 710032, P.R. China. FAU - Guo, Changcun AU - Guo C AD - State Key Laboratory of Cancer Biology, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an 710032, P.R. China. FAU - Pan, Yanglin AU - Pan Y AD - State Key Laboratory of Cancer Biology, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an 710032, P.R. China. FAU - Liang, Shuhui AU - Liang S AD - State Key Laboratory of Cancer Biology, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an 710032, P.R. China. FAU - Wang, Biaoluo AU - Wang B AD - State Key Laboratory of Cancer Biology, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an 710032, P.R. China. FAU - Ding, Jie AU - Ding J AD - State Key Laboratory of Cancer Biology, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an 710032, P.R. China. FAU - Zhang, Hongwei AU - Zhang H AD - State Key Laboratory of Cancer Biology, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an 710032, P.R. China. FAU - Shi, Yongquan AU - Shi Y AD - State Key Laboratory of Cancer Biology, Xijing Hospital of Digestive Diseases, Fourth Military Medical University, Xi'an 710032, P.R. China. LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20140515 PL - Greece TA - Oncol Rep JT - Oncology reports JID - 9422756 RN - 0 (Antigens, Neoplasm) RN - 0 (Antineoplastic Agents, Phytogenic) RN - 0 (Laminin) RN - 0 (MGr1-antigen, human) RN - 5J49Q6B70F (Vincristine) SB - IM MH - Animals MH - Antigens, Neoplasm/*genetics/*metabolism MH - Antineoplastic Agents, Phytogenic/therapeutic use MH - Apoptosis/drug effects MH - Cell Adhesion/drug effects MH - Cell Line, Tumor MH - Drug Resistance, Neoplasm/*drug effects MH - Extracellular Matrix/*metabolism MH - Female MH - Gene Expression Regulation, Neoplastic/drug effects MH - Humans MH - Laminin/*metabolism MH - Mice MH - Mice, Nude MH - Neoplasms, Experimental MH - Stomach Neoplasms/drug therapy/genetics/*pathology MH - Vincristine/therapeutic use EDAT- 2014/05/21 06:00 MHDA- 2015/01/15 06:00 CRDT- 2014/05/21 06:00 PHST- 2014/02/10 00:00 [received] PHST- 2014/03/22 00:00 [accepted] PHST- 2014/05/21 06:00 [entrez] PHST- 2014/05/21 06:00 [pubmed] PHST- 2015/01/15 06:00 [medline] AID - 10.3892/or.2014.3184 [doi] PST - ppublish SO - Oncol Rep. 2014 Jul;32(1):105-14. doi: 10.3892/or.2014.3184. Epub 2014 May 15.